Amr Kronfol - 06 Apr 2022 Form 4 Insider Report for SOC Telemed, Inc.

Reporting relationship: Former Director
Issuer ticker: N/A
Reported as of: 06 Apr 2022
Net transaction value: -$303,975
SEC form: 4
Accepted by SEC: 07 Apr 2022, 16:24:12 UTC
Prior SEC filing: 07 Jun 2021
Source filing: View source filing
Reporting owner signature: /s/ Eunice Kim, as Attorney-in-Fact

Key filing fact

Amr Kronfol filed Form 4 for SOC Telemed, Inc. on 07 Apr 2022.

Key facts

This page summarizes Amr Kronfol's Form 4 filing for SOC Telemed, Inc..
2 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 07 Apr 2022, 16:24.

Change

Previous filing in this sequence was filed on 07 Jun 2021.
Current net transaction value: -$303,975.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

TLMD transaction

Class A Common Stock

Disposed to Issuer

Transaction value: $303,975
Shares: -101,325
Change %: -100%
Price: $3.00
Shares after: 0
Date: 06 Apr 2022
Ownership: Direct
Footnotes: F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

TLMD transaction Derivative

Stock Options

Disposed to Issuer

Transaction value
Shares: -29,437
Change %: -100%
Price
Shares after: 0
Date: 06 Apr 2022
Ownership: Direct
Underlying class: Class A Common Stock
Underlying amount: 29,437
Exercise price: $2.48
Footnotes: F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Section 16 status

Amr Kronfol is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.

Explanation of responses 2 footnotes

Footnote F1

On April 6, 2022, pursuant to the Agreement and Plan of Merger (the "Merger Agreement"), dated as of February 2, 2022, by and among SOC Telemed, Inc. (the "Issuer"), Spark Parent, Inc. ("Parent") and Spark Merger Sub, Inc. ("Merger Sub"), pursuant to which Merger Sub was merged with and into the Issuer (the "Merger"), with the Issuer surviving the Merger as a direct, wholly owned subsidiary of Parent, each share of the Issuer's Class A Common Stock (other than certain excluded shares) outstanding as of immediately prior to the effective time of the Merger (the "Effective Time") was canceled and automatically converted into the right to receive an amount in cash equal to $3.00 (the "Merger Consideration"), without any interest thereon and subject to any applicable withholding taxes.

Footnote F2

These stock options were fully vested as of the Effective Time. Pursuant to the Merger Agreement, each option that was vested in accordance with its terms and outstanding as of immediately prior to the Effective Time was, provided that such option had a per share exercise price less than the Merger Consideration, automatically and without any required action on the part of the holder thereof, canceled and converted into the right to receive an amount in cash, without interest, equal to (i) the total number of shares of Class A Common Stock underlying such option multiplied by (ii) the excess of (A) the Merger Consideration over (B) the per share exercise price for such option, subject to applicable withholding taxes.